Concord Biotech’s stock has witnessed a notable rise, reaching to ₹2,256.95 with a gain of ₹75.40, or 3.46%, as of 10:33 AM.
The shares opened at ₹2,197.20, reaching a high of ₹2,299.95 and a low of ₹2,132.50 during intraday trading, showcasing strong market interest. The stock’s previous close was ₹2,181.55, reflecting positive investor sentiment.
This upward trend may indicate growing confidence in Concord Biotech’s strategic initiatives and future growth potential. Investors should stay updated as the day progresses.
